Biotest Aktiengesellschaft
Save
1.39B
Market cap
9.4x
Current P/E
526.32x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.

Similar securities

Based on sector and market capitalization

Report issue